Literature DB >> 24811410

Tamiflu: "a nice little earner".

Andrew Jack1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24811410     DOI： 10.1136/bmj.g2524

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Antiviral medications for influenza.

Authors:  Christina Korownyk; Scott Garrison; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-04       Impact factor: 3.275

Review 2.  Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system.

Authors:  Madhura Punekar; Manas Kshirsagar; Chaitanya Tellapragada; Kanchankumar Patil
Journal:  Microb Pathog       Date:  2022-05-30       Impact factor: 3.848

3.  The Tamiflu fiasco and lessons learnt.

Authors:  Yogendra Kumar Gupta; Meenakshi Meenu; Prafull Mohan
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

Review 4.  Impact of data transparency: Scientific publications.

Authors:  Mohit Joshi; Payal Bhardwaj
Journal:  Perspect Clin Res       Date:  2018 Jan-Mar

5.  Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.

Authors:  Andreas Vilhelmsson; Shai Mulinari
Journal:  J Public Health (Oxf)       Date:  2018-09-01       Impact factor: 2.341
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.